ANEB logo

Anebulo Pharmaceuticals (ANEB) Enterprise Value

Enterprise Value

$39.31 M
+$778.00 K+2.02%

Fri, 07 Feb 2025 21:00:00 GMT


Summary


Performance

ANEB Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherANEBvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

ANEB Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+2.0%+1.9%+1.9%
1 m1 month-4.4%-4.3%-4.3%
3 m3 months+3.4%+3.3%+3.3%
6 m6 months-18.5%-20.7%-20.7%
ytdytd-6.8%-6.5%-6.5%
1 y1 year-34.5%-38.9%-38.9%
5 y5 years---

ANEB Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-6.2%$36 M+7.8%
3 m3-month$44 M-10.1%$23 M+73.6%
6 m6-month$70 M-43.5%$23 M+73.6%
1 y1-year$76 M-48.1%$23 M+73.6%
3 y3-year$162 M-75.7%$23 M+73.6%
5 y5-year$205 M-80.8%$23 M+73.6%
alltimeall time$205 M-80.8%$23 M+73.6%

Anebulo Pharmaceuticals Enterprise Value History

DateValue
2025
$39.31 M(-6.8%)
2024
$42.16 M(-24.9%)
DateValue
2023
$56.11 M(+22.6%)
2022
$45.78 M(-63.5%)
2021
$125.56 M

FAQ

  • What is Anebulo Pharmaceuticals enterprise value?
  • What is the all time high enterprise value for Anebulo Pharmaceuticals?
  • What is ANEB enterprise value year-to-date change?
  • What is Anebulo Pharmaceuticals enterprise value year-on-year change?

What is Anebulo Pharmaceuticals enterprise value?

The current enterprise value of ANEB is $39.31 M

What is the all time high enterprise value for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals all-time high enterprise value is $204.93 M

What is ANEB enterprise value year-to-date change?

Anebulo Pharmaceuticals enterprise value has changed by -$2.85 M (-6.77%) since the beginning of the year

What is Anebulo Pharmaceuticals enterprise value year-on-year change?

Over the past year, ANEB enterprise value has changed by -$20.69 M (-34.49%)